Previous close | 1.3800 |
Open | 1.3600 |
Bid | 1.3500 x 27000 |
Ask | 1.3800 x 36100 |
Day's range | 1.3150 - 1.4000 |
52-week range | 1.1600 - 6.8800 |
Volume | |
Avg. volume | 6,417,796 |
Market cap | 388.194M |
Beta (5Y monthly) | 2.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3280 |
Earnings date | 02 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.67 |
Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every...
At this time, I would like to turn the conference over to Amy Conrad from investor relations. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. After market closed today, Bionano issued a press release announcing its financial results for the first quarter of 2022.
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -37.50% and 5.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?